You are here
Consultations
We consult on proposed changes to the way we regulate medicines, medical devices and biologicals. Additional consultations about changes to the Poisons Standard can be found in the Scheduling decisions (interim) section of our publications hub.
See all open and recent consultations, submissions and decisions at the TGA Consultation hub.
More on consultations
Find more scheduling consultations on the Poisons Standard in our Interim decisions.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (74)
- Therapeutic goods regulation (18)
- Over the counter (OTC) medicines (14)
- Prescription medicines (14)
- Legislation (11)
- Complementary medicines (9)
- Non-prescription medicines (9)
- Advisory bodies and committees (8)
- Listed medicines (8)
- Labelling and packaging (6)
- Manufacturing (6)
- Medical devices safety (4)
- Advertising (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Medicines safety (3)
- Sunscreens (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Shortages (2)
- Artificial Intelligence (AI) (1)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Please use the filters or search function to help find relevant consultations.
Results for
"[search-keyword]"
Search
243 result(s) found, displaying 126 to 150
-
Closed onConsultationConsultation on proposed adoption or non-adoption of EU and ICH guidelines. Closing date: 7 Feb 2020
-
Closed onConsultationThe TGA is seeking comments from interested parties on an update to guidance for the Export of therapeutic goods from Australia.
-
Closed onConsultationThe closing date of this consultation has been extended. Closing date: 6 December 2019
-
Closed onConsultationThe final date for public submissions to the consultation has been extended to 31 October 2019
-
Closed onConsultationTGA is seeking comments on clarification of the regulation of products used for and by people with disabilities. Closes: 25 October 2019
-
Closed onConsultationThe Secretary invites public submissions on the scheduling proposals referred to the November 2019 meetings of the ACMS and joint ACCS/ACMS. Closing date: 17 October 2019
-
Closed onConsultationThe TGA is seeking comments on the proposed changes to the essential principles for safety and performance of medical devices. Closing date: 17 October 2019
-
Closed onConsultationThese proposed ingredient changes have been reviewed and categorised as being of low-negligible risk. Closing date: 11 October 2019
-
Closed onConsultationWe are seeking feedback on a proposal to publish the names of excipient ingredients used in therapeutic goods in the public view of the Australian Register for Therapeutic Goods (ARTG).
-
IMDRF consultation: Good Regulatory Review Practices - Requirements for Conformity Assessment Bodies
Closed onConsultationDraft IMDRF document. Closing date: 3 October 2019 -
Closed onConsultationThe Secretary invites public submissions on the scheduling proposals referred to the November 2019 meetings of the ACMS and ACCS. Closing date: 26 September 2019
-
Closed onConsultationThe TGA sought comments from interested parties on the making of an order under subsection 7(1) of the Therapeutic Goods Act 1989. Closing date 18 September 2019
-
Closed onConsultationThe TGA invites interested parties to comment on the IMDRF consultation document. Closing date: 24 July 2019
-
Closed onConsultationThe Secretary invites public submissions on these late additions to the scheduling proposals referred to the June 2019 meeting of the ACCS. Closing date: 24 May 2019
-
Closed onConsultationProposed amendments to the Poisons Standard are now available for public comment. Closing date 13 May 2019
-
Closed onConsultationThis consultation considers the EU regulatory framework as an input into the review and reform of the Australian regulatory requirements for medical devices classification. Closing date: 29 April 2019
-
Closed onConsultationThis consultation paper considers the EU regulatory framework as an input into the review and reform of the Australian regulatory requirements for medical devices classification. Closing date: 29 April 2019
-
Closed onConsultationThis consultation paper considers the EU regulatory framework as an input into the review and reform of the Australian regulatory requirements for medical devices classification. Closing date: 29 April 2019
-
Closed onConsultationThis consultation considers the EU regulatory framework as an input into the review and reform of the Australian regulatory requirements for medical devices classification. Closing date: 29 April 2019
-
Closed onConsultationThis consultation paper considers the EU regulatory framework as an input into the review and reform of the Australian regulatory requirements for medical devices classification. Closing date: 29 April 2019
-
Closed onConsultationThrough a targeted consultation, the TGA invited views of a number of stakeholders on proposed options for process improvements
-
Closed onConsultationThe TGA sought comments from interested parties on the proposed criteria, accompanying guidance and plans for monitoring of the supply of Schedule 3 (S3) Pharmacist only - Appendix M substances. Closing date: 1 April 2019
-
Closed onConsultationThis consultation paper considers the EU regulatory framework as an input into the review and reform of the Australian regulatory requirements for medical devices classification. Closing date: 31 March 2019
-
Closed onConsultationThe TGA sought feedback on how personalised medical devices are regulated in Australia. Closing date: 31 March 2019
-
Closed onConsultationThe TGA sought feedback on how software, including Software as a Medical Device, is regulated in Australia. Closing date: 31 March 2019